Cargando…
TM4SF4 and LRRK2 Are Potential Therapeutic Targets in Lung and Breast Cancers through Outlier Analysis
PURPOSE: To find biomarkers for disease, there have been constant attempts to investigate the genes that differ from those in the disease groups. However, the values that lie outside the overall pattern of a distribution, the outliers, are frequently excluded in traditional analytical methods as the...
Autores principales: | Jung, Kyungsoo, Choi, Joon-Seok, Koo, Beom-Mo, Kim, Yu Jin, Song, Ji-Young, Sung, Minjung, Chang, Eun Sol, Noh, Ka-Won, An, Sungbin, Lee, Mi-Sook, Song, Kyoung, Lee, Hannah, Kim, Ryong Nam, Shin, Young Kee, Oh, Doo-Yi, Choi, Yoon-La |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Cancer Association
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7812009/ https://www.ncbi.nlm.nih.gov/pubmed/32972043 http://dx.doi.org/10.4143/crt.2020.434 |
Ejemplares similares
-
Anti-cancer Activity of Novel TM4SF5-Targeting Antibodies through TM4SF5 Neutralization and Immune Cell-Mediated Cytotoxicity
por: Ahn, Hye-Mi, et al.
Publicado: (2017) -
Therapeutic effects of TM4SF5-targeting chimeric and humanized monoclonal antibodies in hepatocellular and colon cancer models
por: Ko, Dongjoon, et al.
Publicado: (2022) -
N-terminus-independent activation of c-Src via binding to a tetraspan(in) TM4SF5 in hepatocellular carcinoma is abolished by the TM4SF5 C-terminal peptide application
por: Song, Haeng Eun, et al.
Publicado: (2021) -
Targeting TM4SF5 with anti-TM4SF5 monoclonal antibody suppresses the growth and motility of human pancreatic cancer cells
por: Park, Sangkyu, et al.
Publicado: (2020) -
Therapeutic effect of a TM4SF5-specific monoclonal antibody against colon cancer in a mouse model
por: Kim, Young-Eun, et al.
Publicado: (2014)